Altium Capital Management LP Vincerx Pharma, Inc. Transaction History

Altium Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.0 - $0.0 $0 - $0	-107,625 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$0.0 - $27.0 $0 - $2.91 Million	107,625 New	107,625 $1.4 Million
Q1 2021 May 06, 2021	SELL	$22.6 - $31.0 $3.39 Million - $4.65 Million	-150,150 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$12.85 - $19.95 $1.93 Million - $3 Million	150,150 New	150,150 $3.14 Million

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $6.57M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.